Graf Acquisition Corp. IV will restate its financial statements for the year ended December 31, 2022 due to an error in the accounting for the waiver of the deferred underwriting fee in its initial public offering.
AI Assistant
NKGEN BIOTECH INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.